enzalutamide,talazoparib
astellas,pfizer
['talapro,2', 'brca']
talapro -2 ddr cohort subset data : hr 0.19 for brca2 !! interesting cdk12 positive outcomes. reproducibility in 3 studies combining parp with ar inhibition . let s continue honing into precision . #asco2023 
Genitourinary Oncology Section Chief Houston Methodist Cancer Center